News

Boehringer Ingelheim, Eli Lilly to collaborate with Duke Institute for heart disease research

The collaboration will investigate whether empagliflozin can improve outcomes and prevent heart failure in adults with and without diabetes

Read More

May 27, 2020

By : Team ABLE

ICMR formally inducts LifeCell for COVID-19 diagnostic testing

LifeCell has been formally inducted into the Government's approved laboratories to perform diagnostic and confirmatory tests for detecting Covid-19. 

Read More

May 27, 2020

By : Team ABLE

US FDA approves intravenous artesunate to treat severe malaria

Prior to this approval, IV artesunate was only available to patients through the FDA's Expanded Access program, which allowed the U.S. CDC to provide IV artesunate to U.S. patients with severe malaria

Read More

May 27, 2020

By : Team ABLE

Glenmark to commence clinical trial on combination of two anti-viral drugs in hospitalized COVID-19 patients

Glenmark Pharmaceuticals has announced that the company will initiate a new randomized, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir

Read More

May 27, 2020

By : Team ABLE

WHO halts hydroxychloroquine trial in COVID-19 patients due to safety concerns

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.

Read More

May 26, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights